Our R&D department is constantly working on developing new and effective molecular diagnostic kits. The focus of these efforts is to develop RT-PCR based kits. Our studies in the field of molecular microbiology will be the pioneers of important developments for our country.
With the mission of providing fast and effective solutions to the general health needs of our customers and society, we develop high-sensitivite RT-PCR-based tests for the early diagnosis of various types of cancer. These advancements are designed to provide solutions to the most dominant challenges of medicine. Our R&D department works continuously to develop innovative products that will facilitate early diagnosis and treatment processes. These studies are carried out in the light of the ever-changing technology and scientific knowledge pool.
All these processes are carried out in accordance with ISO 9001 and ISO 13485 quality standards, which guarantees the integrity of the process and the quality of our products.